CATX

#2551
Perspective Therapeutics, Inc. Common Stock
3.9 4 USD
-1.99%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
3.90
3.97
Range Annuel
1.96
6.16
Changement quotidien
-1.99%
Changement Mensuel
-0.25%
Evolution sur 6 mois
+66.95%
Changement Annuel
+42.24%
Clôture Précédente
4.0 2
Open
3.9 7
Low
3.9 0
High
3.9 7
Volume
529
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 449.34 M
  • Employee 166
  • Founded 2004
  • CEO N/A
  • Website www.perspectivetherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000BG5HT7
  • Industry Dispositifs Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.96
ratio cours/chiffre d'affaires
229.62

Perspective Therapeutics, Inc. Common Stock

Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354.

Nouvelles